Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy

Penny Fang, Nicholas S. Boehling, Eugene J. Koay, Amanda D. Bucheit, John A. Jakob, Stephen H. Settle, Paul D. Brown, Michael A. Davies, Erik P. Sulman

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences